The effect of intravenous tranexamic acid to reduce blood loss in non union shaft humerus fracture patient undergoing open reduction and plating Randomized control trial

The effect of intravenous tranexamic acid to reduce blood loss in non union shaft humerus fracture patient undergoing open reduction and plating : Randomized control trial

Status

Unknown

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210311001

Enrollment

Registered

2021-03-11

Start date

2021-06-23

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non union midshaft humerus Intravenous tranexamic acid undergoing open reduction and plating

Interventions

intravenous tranexamic acid 750 mg before surgery 15 min ,intravenous tranexamic acid 750 mg before surgery 15 min

Experimental Drug,Placebo Comparator Drug

Intravenous tranexamic acid,control

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis Non union midshaft humerus Patient undergoing open reduction and plalting

Exclusion criteria

Exclusion criteria: 1 History thromboembolism 2 Patient taking anticoagulant or antiplatelate 3 Patient with Renal disease GFR<60 4 Pathologic fracture 5 Infection at fracture area

Design outcomes

Primary

Measure	Time frame
total blood loss intraoperative ml	—

Secondary

Measure	Time frame
Blood transfusion 72 hr unit	—

Countries

Thailand

Contacts

Public ContactPornpanit Dissaneewate

Faculty of medicine ,Prince of Songkla university

Dpornpanit@yahoo.com074451601

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026